Given the reported upregulation of TLR7 and TLR9 expression in B cells from SLE patients [30], [31], [32], [33], [34], it was surprising to see that these cells mounted virtually normal, and sometimes even reduced responses to the stimulation of the corresponding ligands. This evidence concerns the gene TLR9 and systemic lupus erythematosus.